Arnold Ventures Commends Senate on Unanimous Passage of the Affordable Prescriptions for Patients Act
July 12, 2024
July 12, 2024
HOUSTON, Texas, July 12 -- Arnold Ventures (formerly the Laura and John Arnold Foundation) issued the following news:
* * *
Statement from Mark E. Miller, Executive Vice President of Health Care at Arnold Ventures.
* * *
"Reforms to patent law are vital to lowering prescription drug costs, and the Senate's unanimous passage of legislation to prevent pharmaceutical companies from employing 'patent thickets' to extend market exclusivity and . . .
* * *
Statement from Mark E. Miller, Executive Vice President of Health Care at Arnold Ventures.
* * *
"Reforms to patent law are vital to lowering prescription drug costs, and the Senate's unanimous passage of legislation to prevent pharmaceutical companies from employing 'patent thickets' to extend market exclusivity and . . .